Tenaya Therapeutics Funding & Investors

South San Francisco, CA

Tenaya Therapeutics, Inc. operates as a biotechnology company. The Company focuses on discovering and developing novel therapies for heart failure.

Total Amount Raised: $433,500,000

Grant
$8,000,000
Feb 2, 2025
Grant Investors
California Institute for Regenerative Medicine (CIRM)
Post Ipo Equity
$52,500,000
Feb 2, 2025
Post Ipo Equity
$50,000,000
Feb 7, 2024
Post Ipo Equity Investors
Venrock Healthcare Capital Partners
Armistice Capital
Soleus Capital
PFM Health Sciences
Integral Health Asset Management
RA Capital Management
The Column Group
Octagon Capital Advisors
Post Ipo Equity
$75,000,000
Nov 15, 2022
Series C
$106,000,000
Feb 28, 2021
Series C Investors
RTW Investments
RA Capital Management
The Column Group
GV
Casdin Capital
Fidelity Investments
T. Rowe Price
IPO
Unknown
Jan 1, 2021
Series B
$92,000,000
Oct 2, 2019
Series B Investors
Casdin Capital
GV
The Column Group
Greenspring Associates
Series A
$50,000,000
Dec 5, 2016
Series A Investors
The Column Group

Funding info provided by Diffbot.